In-Vivo Proton Magnetic Resonance Spectroscopy of 2-Hydroxyglutarate in Isocitrate Dehydrogenase-Mutated Gliomas: A Technical Review for Neuroradiologists

Overview

Journal Korean J Radiol

Specialty Radiology

Date 2016 Sep 3

PMID 27587950

Citations 13

Authors

Hyeonjin Kim

Sungjin Kim

Hyeong Hun Lee

Hwon Heo

Affiliations

Soon will be listed here.

Abstract

The diagnostic and prognostic potential of an onco-metabolite, 2-hydroxyglutarate (2HG) as a proton magnetic resonance spectroscopy (1H-MRS) detectable biomarker of the isocitrate dehydrogenase (IDH)-mutated (IDH-MT) gliomas has drawn attention of neuroradiologists recently. However, due to severe spectral overlap with background signals, quantification of 2HG can be very challenging. In this technical review for neuroradiologists, first, the biochemistry of 2HG and its significance in the diagnosis of IDH-MT gliomas are summarized. Secondly, various 1H-MRS methods used in the previous studies are outlined. Finally, wereview previous in vivo studies, and discuss the current status of 1H-MRS in the diagnosis of IDH-MT gliomas.

Citing Articles

Detecting Tumor-Associated Intracranial Hemorrhage Using Proton Magnetic Resonance Spectroscopy.

Yoo H, Lee H, Nga V, Choi Y, Lim J Neurol Int. 2024; 16(6):1856-1877.

PMID: 39728759 PMC: 11679972. DOI: 10.3390/neurolint16060133.

Incorporation of Edited MRS into Clinical Practice May Improve Care of Patients with -Mutant Glioma.

Nichelli L, Cadin C, Lazzari P, Mathon B, Touat M, Sanson M AJNR Am J Neuroradiol. 2024; 46(1):113-120.

PMID: 38997123 PMC: 11735446. DOI: 10.3174/ajnr.A8413.

Identification of Metabolomic Markers in Frozen or Formalin-Fixed and Paraffin-Embedded Samples of Diffuse Glioma from Adults.

Chardin D, Jing L, Chazal-Ngo-Mai M, Guigonis J, Rigau V, Goze C Int J Mol Sci. 2023; 24(23).

PMID: 38069019 PMC: 10705927. DOI: 10.3390/ijms242316697.

Non-Invasive Assessment of Isocitrate Dehydrogenase-Mutant Gliomas Using Optimized Proton Magnetic Resonance Spectroscopy on a Routine Clinical 3-Tesla MRI.

de Godoy L, Lim K, Rajan A, Verma G, Hanaoka M, ORourke D Cancers (Basel). 2023; 15(18).

PMID: 37760422 PMC: 10526791. DOI: 10.3390/cancers15184453.

Quantitative relaxometry using synthetic MRI could be better than T2-FLAIR mismatch sign for differentiation of IDH-mutant gliomas: a pilot study.

Kikuchi K, Togao O, Yamashita K, Momosaka D, Kikuchi Y, Kuga D Sci Rep. 2022; 12(1):9197.

PMID: 35654812 PMC: 9163057. DOI: 10.1038/s41598-022-13036-0.

References

Heo H, Kim S, Lee H, Cho H, Xu W, Lee S . On the Utility of Short Echo Time (TE) Single Voxel 1H-MRS in Non-Invasive Detection of 2-Hydroxyglutarate (2HG); Challenges and Potential Improvement Illustrated with Animal Models Using MRUI and LCModel. PLoS One. 2016; 11(1):e0147794. PMC: 4731570. DOI: 10.1371/journal.pone.0147794. View

Shi J, Sun B, Shi W, Zuo H, Cui D, Ni L . Decreasing GSH and increasing ROS in chemosensitivity gliomas with IDH1 mutation. Tumour Biol. 2014; 36(2):655-62. DOI: 10.1007/s13277-014-2644-z. View

Cudalbu C, Mlynarik V, Gruetter R . Handling macromolecule signals in the quantification of the neurochemical profile. J Alzheimers Dis. 2012; 31 Suppl 3:S101-15. DOI: 10.3233/JAD-2012-120100. View

Young K, Soher B, Maudsley A . Automated spectral analysis II: application of wavelet shrinkage for characterization of non-parameterized signals. Magn Reson Med. 1998; 40(6):816-21. DOI: 10.1002/mrm.1910400606. View

Ward P, Patel J, Wise D, Abdel-Wahab O, Bennett B, Coller H . The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell. 2010; 17(3):225-34. PMC: 2849316. DOI: 10.1016/j.ccr.2010.01.020. View

Lopez G, Reitman Z, Solomon D, Waldman T, Bigner D, McLendon R . IDH1(R132) mutation identified in one human melanoma metastasis, but not correlated with metastases to the brain. Biochem Biophys Res Commun. 2010; 398(3):585-7. PMC: 2987603. DOI: 10.1016/j.bbrc.2010.06.125. View

Kang M, Kim M, Oh J, Kim Y, Song S, Seo S . Mutational analysis of IDH1 codon 132 in glioblastomas and other common cancers. Int J Cancer. 2009; 125(2):353-5. DOI: 10.1002/ijc.24379. View

Esmaeili M, Vettukattil R, Bathen T . 2-hydroxyglutarate as a magnetic resonance biomarker for glioma subtyping. Transl Oncol. 2013; 6(2):92-8. PMC: 3610550. DOI: 10.1593/tlo.12424. View

Reitman Z, Jin G, Karoly E, Spasojevic I, Yang J, Kinzler K . Profiling the effects of isocitrate dehydrogenase 1 and 2 mutations on the cellular metabolome. Proc Natl Acad Sci U S A. 2011; 108(8):3270-5. PMC: 3044380. DOI: 10.1073/pnas.1019393108. View

10.

Hofmann L, Slotboom J, Jung B, Maloca P, Boesch C, Kreis R . Quantitative 1H-magnetic resonance spectroscopy of human brain: Influence of composition and parameterization of the basis set in linear combination model-fitting. Magn Reson Med. 2002; 48(3):440-53. DOI: 10.1002/mrm.10246. View

11.

Parsons D, Jones S, Zhang X, Cheng-Ho Lin J, Leary R, Angenendt P . An integrated genomic analysis of human glioblastoma multiforme. Science. 2008; 321(5897):1807-12. PMC: 2820389. DOI: 10.1126/science.1164382. View

12.

Li Y, Srinivasan R, Ratiney H, Lu Y, Chang S, Nelson S . Comparison of T(1) and T(2) metabolite relaxation times in glioma and normal brain at 3T. J Magn Reson Imaging. 2008; 28(2):342-50. PMC: 3033227. DOI: 10.1002/jmri.21453. View

13.

Cavassila S, Deval S, Huegen C, van Ormondt D, Graveron-Demilly D . Cramér-Rao bounds: an evaluation tool for quantitation. NMR Biomed. 2001; 14(4):278-83. DOI: 10.1002/nbm.701. View

14.

Naressi A, Couturier C, Devos J, Janssen M, Mangeat C, de Beer R . Java-based graphical user interface for the MRUI quantitation package. MAGMA. 2001; 12(2-3):141-52. DOI: 10.1007/BF02668096. View

15.

Choi C, Ganji S, DeBerardinis R, Hatanpaa K, Rakheja D, Kovacs Z . 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated patients with gliomas. Nat Med. 2012; 18(4):624-9. PMC: 3615719. DOI: 10.1038/nm.2682. View

16.

Lazovic J, Soto H, Piccioni D, Lou J, Li S, Mirsadraei L . Detection of 2-hydroxyglutaric acid in vivo by proton magnetic resonance spectroscopy in U87 glioma cells overexpressing isocitrate dehydrogenase-1 mutation. Neuro Oncol. 2012; 14(12):1465-72. PMC: 3499014. DOI: 10.1093/neuonc/nos258. View

17.

Terunuma A, Putluri N, Mishra P, Mathe E, Dorsey T, Yi M . MYC-driven accumulation of 2-hydroxyglutarate is associated with breast cancer prognosis. J Clin Invest. 2013; 124(1):398-412. PMC: 3871244. DOI: 10.1172/JCI71180. View

18.

Howe F, Barton S, Cudlip S, Stubbs M, Saunders D, Murphy M . Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med. 2003; 49(2):223-32. DOI: 10.1002/mrm.10367. View

19.

Hetherington H, Avison M, Shulman R . 1H homonuclear editing of rat brain using semiselective pulses. Proc Natl Acad Sci U S A. 1985; 82(10):3115-8. PMC: 397725. DOI: 10.1073/pnas.82.10.3115. View

20.

Andronesi O, Rapalino O, Gerstner E, Chi A, Batchelor T, Cahill D . Detection of oncogenic IDH1 mutations using magnetic resonance spectroscopy of 2-hydroxyglutarate. J Clin Invest. 2013; 123(9):3659-63. PMC: 3754248. DOI: 10.1172/JCI67229. View